Clinical outcomes are similar for abciximab and eptifibatide in patients who undergo percutaneous coronary intervention (PCI), but abciximab is associated with greater costs

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1518, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical outcomes are similar for abciximab and eptifibatide in patients who undergo percutaneous coronary intervention (PCI), but abciximab is associated with greater costs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 493, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Impact of Abciximab in Elderly Patients with High-Risk Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Observational Registry Study

By Iversen Allan Z.   Galatius Soeren   Pedersen Sune   Madsen Jan K.   Jensen Jan S.  

Drugs & Aging, Vol. 28, Iss. 5, 2011-05 ,pp. : 369-378

Adis International

Access to resources Recommend Favorite

Eptifibatide beneficial in patients scheduled to undergo percutaneous coronary interventions

By  

Inpharma, Vol. 1, Iss. 1269, 2001-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

Spotlight on Abciximab in Patients with Ischemic Heart Disease Undergoing Percutaneous Coronary Revascularization

By Ibbotson T.   McGavin J.K.   Goa K.L.  

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 5, 2003-01 ,pp. : 381-386

Adis International

Access to resources Recommend Favorite

Association between Abciximab and Length of Stay in Intensive Care for Patients Undergoing Percutaneous Coronary Intervention: A 2-Stage Econometric Model in a Naturalistic Setting

By Lage M.J.  

PharmacoEconomics, Vol. 18, Iss. 6, 2000-12 ,pp. : 581-589

Adis International

Access to resources Recommend Favorite